Piroxicam is indicated for the short-term symptomatic treatment of rheumatoid arthritis or ankylosing spondylitis. Due to its tolerance profile (see sections 4.2, 4.3, and 4.4), piroxicam should not be used as a first-line treatment when an NSAID is indicated.
The decision to prescribe a medicine containing piroxicam should be based on the assessment of all risks specific to each patient (see sections 4.3 and 4.4).
REMIFENTANIL is indicated as an analgesic agent during the induction and/or maintenance of general anesthesia. REMIFENTANIL is indicated for analgesia in patients aged 18 years and older who are mechanically ventilated in an intensive care unit.
REMIFENTANIL is indicated as an analgesic agent during the induction and/or maintenance of general anesthesia. REMIFENTANIL is indicated for analgesia in patients aged 18 years and older who are mechanically ventilated in an intensive care unit.
REMIFENTANIL is indicated as an analgesic agent during the induction and/or maintenance of general anesthesia. REMIFENTANIL is indicated for analgesia in patients aged 18 years and older who are mechanically ventilated in an intensive care unit.
This medication is indicated in non-insulin-dependent (type 2) diabetes mellitus in adults, when diet, exercise, and weight reduction alone are not sufficient to restore glycemic balance.
Treatment of essential hypertension in adults. RETAZID, a fixed-dose combination, is indicated in patients whose blood pressure is not adequately controlled with valsartan or hydrochlorothiazide monotherapy.
Treatment of essential hypertension in adults. RETAZID, a fixed-dose combination, is indicated in patients whose blood pressure is not adequately controlled with valsartan or hydrochlorothiazide monotherapy.
Treatment of essential hypertension in adults. RETAZID, a fixed-dose combination, is indicated in patients whose blood pressure is not adequately controlled with valsartan or hydrochlorothiazide monotherapy.
Symptomatic treatment of mild to moderate pain and/or fever. This presentation is reserved for adults and children weighing at least 27 kg (approximately 8 years old).
Short-term treatment of moderate pain, particularly in the postoperative period, and short-term treatment of fever when the intravenous route is clinically justified by the urgency of treating pain or hyperthermia and/or when other routes of administration are not possible.